City

Bethesda (1)

Condition

Drug Evaluation (2)

Colitis (1)

Cutaneous Leishmaniases (1)

Cytokines (1)

Hermanski-Pudlak Syndrome (1)

Lymphocytes (1)

Primary Health Care (1)

Treatment Adherence (1)

Overall Status

Not yet recruiting (1)

Withdrawn (1)

Sign in for free

Phase

phase 2 (1)

Sponsor

Centre Hospitalier de Cayenne (1)

National Institute of Allergy and Infectious Diseases (NIAID) (1)

Collaborator

Intervention

6-mercaptopurine (1)

adalimumab (1)

corticosteroids (1)

data collection (1)

infliximab (1)

mesalamine (1)

questionnaires (1)

tacrolimus (1)

Study Documents

Intervention Type

drug (1)

other (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (1)

Observational (1)

drug evaluation

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

LAST UPDATED

Cases of Cutaneous Leishmaniasis Treated With Miltefosine in

Not yet recruiting

Cutaneous Leishmaniases
+3 more

Data collection
Questionnaires

(no location specified)

Aug 5, 2022

Hermanski-Pudlak Syndrome, Colitis, Cytokines Trial run by the NIAID (Mesalamine, Infliximab, Corticosteroids)

Withdrawn

Hermanski-Pudlak Syndrome
+4 more

Mesalamine
+5 more

Bethesda, Maryland

National Institutes of Health Clinical Center, 9000 Rockville Pi

Jun 30, 2017